There are an estimated 190 core biotech and 460 biotech-related companies operating in Australia Approximately 35 core biotech companies and 25 biotech-related companies are publicly listed The ...
Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...
Hosted on MSN
Biotech Sector May Flip to Market Leader by Year-End
The biotech sector has been one of the market's laggards for several years now, and 2025 has been no different, at least on the surface. Year-to-date, the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB ...
The Invesco Health Care Fund underperformed its benchmark in Q1 2026 due to poor stock selection in pharmaceuticals. Read the ...
On Monday, Vera TherapeuticsVERA hit an important technical milestone, with its Relative Strength (RS) Rating moving into the 90-plus percentile with an upgrade to 91, up from 88 the day before. How ...
Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...
Platinum Biologics highlights stronger compliance standards, responsible innovation, and leadership in the evolving biotech regulatory landscape across emerging biotech markets. ORLANDO, FL / ACCESS ...
Across the recent three months, 7 analysts have shared their insights on Krystal Biotech (NASDAQ:KRYS), expressing a variety of opinions spanning from bullish to bearish. The following table provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results